These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22078334)

  • 1. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.
    Winter C; Pfister D; Busch J; Bingöl C; Ranft U; Schrader M; Dieckmann KP; Heidenreich A; Albers P
    Eur Urol; 2012 Feb; 61(2):403-9. PubMed ID: 22078334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
    Paffenholz P; Pfister D; Heidenreich A
    Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
    Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann JT; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
    J Clin Oncol; 2004 Sep; 22(18):3713-9. PubMed ID: 15365067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of retroperitoneal lymph node dissection for patients with advanced germ cell tumors].
    Okamura K; Yuba H; Nishimura T; Mizutani K; Takashi M; Gotoh M; Ono Y; Ohshima S
    Hinyokika Kiyo; 1999 Feb; 45(2):95-101. PubMed ID: 10212781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
    Albers P; Weissbach L; Krege S; Kliesch S; Hartmann M; Heidenreich A; Walz P; Kuczyk M; Fimmers R;
    J Urol; 2004 May; 171(5):1835-8. PubMed ID: 15076288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of advanced seminoma: retrospective study of 96 patients].
    Bompas E; Fléchon A; Biron P; Droz JP
    Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
    Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
    Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
    Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular origin.
    Schirren J; Trainer S; Eberlein M; Lorch A; Beyer J; Bölükbas S
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):405-12. PubMed ID: 22383152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers].
    Matveev VB; Volkova MI; Cherniev VA; Figurin KM; Mitin AV
    Urologiia; 2010; (3):41-7. PubMed ID: 20734877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy.
    Copson E; McKendrick J; Hennessey N; Tung K; Mead GZ
    BJU Int; 2004 Sep; 94(4):552-8. PubMed ID: 15329111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
    Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
    J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.
    Richie JP
    J Urol; 2013 Jan; 189(1):128-9. PubMed ID: 23235218
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
    Fizazi K; Delva R; Caty A; Chevreau C; Kerbrat P; Rolland F; Priou F; Geoffrois L; Rixe O; Beuzeboc P; Malhaire JP; Culine S; Aubelle MS; Laplanche A
    Eur Urol; 2014 Feb; 65(2):381-6. PubMed ID: 24094847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer.
    Onozawa M; Kawai K; Yamamoto T; Hinotsu S; Tsukamoto S; Hattori K; Miyanaga N; Shimazui T; Akaza H
    Int J Urol; 2004 Jul; 11(7):535-41. PubMed ID: 15242364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.